<h4>Background</h4>The role of erythroferrone, a hormone synthesized in erythroid cells that suppresses hepatic production of hepcidin to increase systemic iron availability during erythropoiesis expansion, has not been sufficiently characterized in chronic kidney disease (CKD). This evidence concerns the gene HAMP and chronic kidney disease.